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response to standing up, and 5) blood pressure response to a sustained 
handgrip.
There are other approaches for evaluating the autonomic nervous 
system by heart rate variability (HRV) parameters from short- or long-
term monitoring (2). We agree that HRV and bedside autonomic function 
tests for evaluating the autonomic nervous system provide complemen-
tary information regarding autonomic regulatory mechanisms in health 
and disease. However, the bedside autonomic function tests were more 
feasible for us during the study.
We also considered that spectrum bias may account for differenc-
es in the reported results between the investigations.
Therefore, in order to point out the difference between the cardio-
vascular autonomic function of RA patients and general population, we 
will design another prospective cohort study with complementary and 
more sensitive tests.
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Restless leg syndrome and slow 
coronary flow. Is it inflammation or 
autonomic nervous system?
To the Editor,
Erden et al. (1) recently published a very interesting paper in the 
Anatolian Journal of Cardiology 2014; 14: 612-6 entitled “Association 
between restless leg syndrome and slow coronary flow,” which sug-
gests an association between the coronary slow flow (CSF) phenome-
non and restless leg syndrome. The article showed that patients with 
the CSF phenomenon were more likely to suffer from restless leg syn-
drome compared to subjects with normal coronary flow. Although, I 
appreciate the authors for their work, there are some issues that need 
to be clarified in order to glean more data from the article.  The defini-
tion of CSF relies upon TIMI frame count (TFC), which varies depending 
on the image acquisition rate. The authors chose a recording speed of 
25 frames/s. Still, they defined CSF according to the criteria based on 
the reference values of Gibson et al. (2). “a TFC greater than two stan-
dard deviations from the normal range for a particular coronary artery.” 
Gibson used a frame rate of 30/s. Thus, the authors could have underesti-
mated TFC. I believe that they need to multiply their corrected TFC with a 
factor of 1.2 in order to find the real corrected TFC, which may render 
some of their normal patients into a group of CSF (2, 3). It would be appro-
priate to know the mean cTFC values of patients with the CSF phenome-
non and those of the normal patients in this regard. Even though the 
authors reported the overall prevalence of restless leg syndrome, it would 
be useful to know how many patients with and without the CSF phenom-
enon had restless leg syndrome.  In our current practice, we do not come 
across patients having both the CSF phenomenon and restless leg syn-
drome, thus, they may have mild symptoms. Was there any association 
with symptom severity and TFC? We previously showed that patients with 
the CSF phenomenon had attenuated heart rate recovery, suggesting 
impaired vagal activation of the cardiovascular system (4). Therefore, we 
agree with the authors that the common link between the CSF phenome-
non and restless leg syndrome is the probably autonomic nervous system.
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Author`s Reply
To the Editor,
We thank to Tekin for her interest in our investigation entitled 
“Association between restless leg syndrome and slow coronary flow” 
published in Anatol J Cardiol 2014; 14: 612-6 (1).
Some standard recommendations are made for the quantitative 
analysis of epicardial blood flow. Pérez de Prado et al. (2) reported that 
imaging speed should ideally be 25 frames/s. Nevertheless, the cor-
rected TIMI frame count (cTFC) can be calculated at any recording 
speed, and subsequently it can be expressed in seconds or adjusted to 
the recommended speed. The images obtained by cineangiography in 
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the study by Gibson et al. (3) were recorded at the rate of 30 frames/s. 
When we evaluated our findings according to the rate of 30 frames/s, 
there was no statistically significant change in the association between 
restless legs syndrome (RLS) and coronary slow flow (CSF).
Ohayon et al. (4) reported RLS prevalence in the general adult 
population.
1) A symptom only: ranged from 9.4% to 15%,
2) A set of symptoms meeting the minimal diagnostic criteria of the 
international RLS study group: ranged from 3.9% to 14.3%,
3) Meeting minimal criteria accompanied with a specific frequency 
and/or severity: ranged from 2.2% to 7.9%,
4) A differential diagnosis: ranged from 1.9% and 4.6%.
In our study, 33 subjects (38%) had RLS with the CSF phenomenon, 
and 15 (17%) had RLS without the CSF phenomenon (1). The prevalence 
of RLS in our control group was slightly higher than the prevalence of 
Ohayon’s (4) study. Previously, we found that (5) the prevalence of RLS 
in hypertensive patients was more than twice as frequent as that in 
normotensive individuals (35.3 vs. 17.2%, respectively, p<0.01).
Additionally, there were significant but weak correlations between 
mean TFC (r=0.268, p<0.001), LAD TFC (r=0.322, p<0.001), and RCA TFC 
(r=0.117, p=0.02) and severity of RLS. There was no significant correla-
tion between Cx TFC and severity of RLS. 
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Ultrasound-assisted catheter-directed 
thrombolysis for pulmonary embolism
To the Editor,
We have read through the case report article with great interest, 
entitled “Combined catheter thrombus fragmentation and percutane-
ous thrombectomy in a patient with massive pulmonary emboli and 
acute cerebral infarct,” by Uğurlu et al. (1) and published in Anatol J 
Cardiol 2015; 15: 69-74. For the last two years, ultrasound-assisted 
catheter-directed thrombolytic (USAT) has been used as an alternative 
method for treatment in selected cases (2). We believe that massive 
pulmonary embolism can be a life-saving treatment option in experi-
enced centers of the percutaneous intervention. However, we have 
some concerns about employing it in “intermediate-high” group 
patients. In this article, we would like to present a successful USAT on 
a patient to whom a prior thrombolytic treatment had been applied. 
However, this initial thrombolytic treatment had ended with failure and 
a bleeding complication had developed.
A 75-year-old female patient with hemiplegia showed thrombus in 
bilateral main pulmonary arteries in CT pulmonary angiogram (CTPA) 
performed at another center, and developed respiratory and cardiac 
failures. The patient was given thrombolytic treatment; however, her 
hypoxemia got deeper in spite of anticoagulant treatment. The patient 
whose thrombolytic treatment was in the “intermediate-high” category 
with respect to mortality risk, pulmonary embolism severity index was 
175, and Wells bleeding risk score was 4, was admitted to the intensive 
care treatment. Since the probability of mortality was determined as 
10–25% within the first 30 days, systemic thrombolytic treatment failed, 
and since the bleeding risk remained high, USAT was planned. 
Angiography for USAT was performed under local anesthesia during 
invasive mechanical ventilator support. Mean pulmonary artery pres-
sure was found to be 53 mm Hg. 5 mg tPA bolus was administered 
through each catheter to maintain the patency of catheters and receive 
an immediate response. Following a total 10 mg push, a continuous tPA 
infusion was initiated as 1 mg/h dose for the first 5 hours, and 0.5 mg/h 
dose for the following 10 hours time. In addition to tPA, the patient was 
administered systemic unfractionated heparin. Echocardiographic eval-
uation on the fifth day of treatment revealed that pulmonary artery pres-
sure and right ventricular functions were back to normal. CTPA showed 
almost complete resolution of thrombi within the pulmonary arteries.
According to Uğurlu et al. (1), percutaneous intervention is a life-
saving treatment option in massive PE treatment. USAT treatment was 
found to be especially effective at the right ventricular dilatation with-
out causing any hemorrhage, compared with unfractionated heparin 
infusion in patients diagnosed with intermediate-risk PE (3). In conclu-
sion, our case indicates that USAT is a safely usable option for treating 
massive and sub-massive PE’s with high-risk of bleeding and is unre-
sponsive to systemic thrombolytic treatments.
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